Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells

Fusaric acid (FA) is a food-borne mycotoxin that mediates toxicity with limited information on its epigenetic properties. p53 is a tumour suppressor protein that regulates cell cycle arrest and apoptotic cell death. The expression of p53 is regulated transcriptionally by promoter methylation and pos...

Full description

Bibliographic Details
Main Authors: Terisha Ghazi, Savania Nagiah, Anil A. Chuturgoon
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Epigenetics
Subjects:
Online Access:http://dx.doi.org/10.1080/15592294.2020.1788324
_version_ 1797678895527362560
author Terisha Ghazi
Savania Nagiah
Anil A. Chuturgoon
author_facet Terisha Ghazi
Savania Nagiah
Anil A. Chuturgoon
author_sort Terisha Ghazi
collection DOAJ
description Fusaric acid (FA) is a food-borne mycotoxin that mediates toxicity with limited information on its epigenetic properties. p53 is a tumour suppressor protein that regulates cell cycle arrest and apoptotic cell death. The expression of p53 is regulated transcriptionally by promoter methylation and post-transcriptionally by N-6-methyladenosine (m6A) RNA methylation. We investigated the effect of FA on p53 expression and its epigenetic regulation via promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells. HepG2 cells were treated with FA [0, 25, 50, 104, and 150 µg/ml; 24 h] and thereafter, DNA, RNA, and protein was isolated. Promoter methylation and expression of p53 was measured using qPCR and Western blot. RNA immuno-precipitation was used to determine m6A-p53 levels. The expression of m6A methyltransferases (METTL3 and METTL14), demethylases (FTO and ALKBH5), and readers (YTHDF1-3 and YTHDC2) were measured using qPCR. FA induced p53 promoter hypermethylation (p < 0.0001) and decreased p53 expression (p < 0.0001). FA decreased m6A-p53 levels (p < 0.0001) by decreasing METTL3 (p < 0.0001) and METTL14 (p < 0.0001); and suppressed expression of YTHDF1 (p < 0.0001), YTHDF3 (p < 0.0001), and YTHDC2 (p < 0.0001) that ultimately reduced p53 translation (p < 0.0001). Taken together, the data shows that FA epigenetically decreased p53 expression by altering its promoter methylation and m6A RNA methylation in HepG2 cells. This study reveals a mechanism for p53 regulation by FA and provides insight into future therapeutic interventions.
first_indexed 2024-03-11T23:05:32Z
format Article
id doaj.art-76042b7a691742cebb57d9211e64f53b
institution Directory Open Access Journal
issn 1559-2294
1559-2308
language English
last_indexed 2024-03-11T23:05:32Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Epigenetics
spelling doaj.art-76042b7a691742cebb57d9211e64f53b2023-09-21T13:09:24ZengTaylor & Francis GroupEpigenetics1559-22941559-23082021-01-01161799110.1080/15592294.2020.17883241788324Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cellsTerisha Ghazi0Savania Nagiah1Anil A. Chuturgoon2School of Laboratory Medicine and Medical Science, College of Health Sciences, Howard College Campus, University of KwaZulu-NatalSchool of Laboratory Medicine and Medical Science, College of Health Sciences, Howard College Campus, University of KwaZulu-NatalSchool of Laboratory Medicine and Medical Science, College of Health Sciences, Howard College Campus, University of KwaZulu-NatalFusaric acid (FA) is a food-borne mycotoxin that mediates toxicity with limited information on its epigenetic properties. p53 is a tumour suppressor protein that regulates cell cycle arrest and apoptotic cell death. The expression of p53 is regulated transcriptionally by promoter methylation and post-transcriptionally by N-6-methyladenosine (m6A) RNA methylation. We investigated the effect of FA on p53 expression and its epigenetic regulation via promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells. HepG2 cells were treated with FA [0, 25, 50, 104, and 150 µg/ml; 24 h] and thereafter, DNA, RNA, and protein was isolated. Promoter methylation and expression of p53 was measured using qPCR and Western blot. RNA immuno-precipitation was used to determine m6A-p53 levels. The expression of m6A methyltransferases (METTL3 and METTL14), demethylases (FTO and ALKBH5), and readers (YTHDF1-3 and YTHDC2) were measured using qPCR. FA induced p53 promoter hypermethylation (p < 0.0001) and decreased p53 expression (p < 0.0001). FA decreased m6A-p53 levels (p < 0.0001) by decreasing METTL3 (p < 0.0001) and METTL14 (p < 0.0001); and suppressed expression of YTHDF1 (p < 0.0001), YTHDF3 (p < 0.0001), and YTHDC2 (p < 0.0001) that ultimately reduced p53 translation (p < 0.0001). Taken together, the data shows that FA epigenetically decreased p53 expression by altering its promoter methylation and m6A RNA methylation in HepG2 cells. This study reveals a mechanism for p53 regulation by FA and provides insight into future therapeutic interventions.http://dx.doi.org/10.1080/15592294.2020.1788324fusaric acidp53promoter methylationepitranscriptomicsm6a rna methylation
spellingShingle Terisha Ghazi
Savania Nagiah
Anil A. Chuturgoon
Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells
Epigenetics
fusaric acid
p53
promoter methylation
epitranscriptomics
m6a rna methylation
title Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells
title_full Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells
title_fullStr Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells
title_full_unstemmed Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells
title_short Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells
title_sort fusaric acid decreases p53 expression by altering promoter methylation and m6a rna methylation in human hepatocellular carcinoma hepg2 cells
topic fusaric acid
p53
promoter methylation
epitranscriptomics
m6a rna methylation
url http://dx.doi.org/10.1080/15592294.2020.1788324
work_keys_str_mv AT terishaghazi fusaricaciddecreasesp53expressionbyalteringpromotermethylationandm6arnamethylationinhumanhepatocellularcarcinomahepg2cells
AT savanianagiah fusaricaciddecreasesp53expressionbyalteringpromotermethylationandm6arnamethylationinhumanhepatocellularcarcinomahepg2cells
AT anilachuturgoon fusaricaciddecreasesp53expressionbyalteringpromotermethylationandm6arnamethylationinhumanhepatocellularcarcinomahepg2cells